The latest closing stock price for Entero Therapeutics as of January 17, 2025 is 0.54.
An investor who bought $1,000 worth of Entero Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -79.98% compound annual growth rate over 8 years.
The all-time high Entero Therapeutics stock closing price was 230159.98 on October 12, 2016.
The Entero Therapeutics 52-week high stock price is 9.35, which is 1631.5% above the current share price.
The Entero Therapeutics 52-week low stock price is 0.18, which is 66.7% below the current share price.
The average Entero Therapeutics stock price for the last 52 weeks is 2.04.
An investor who bought $1,000 worth of Entero Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -79.98% compound annual growth rate over 8 years.
The all-time high Entero Therapeutics stock closing price was 230159.98 on October 12, 2016.
The Entero Therapeutics 52-week high stock price is 9.35, which is 1631.5% above the current share price.
The Entero Therapeutics 52-week low stock price is 0.18, which is 66.7% below the current share price.
The average Entero Therapeutics stock price for the last 52 weeks is 2.04.